| C09DB01 |
Amlodipine/ Valsartan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09DB01 |
Amlodipine, Valsartan |
Exforge |
Film‐coated tablet |
5 mg/160 mg |
mg |
28 |
Novartis Europharm Limited, Обединено Кралство |
1 |
tabl. |
- |
41.23 |
0.27783 |
7.78 |
50% |
3.89 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 164/ 20.04.2011; КЦРР-646/19.05.2012 г.; НСР-3293/24.04.2014; НСР-5316/ 18.12.2014.; НСР-7229/15.10.2015. |
02.04.2016 |
08.09.2012 |
|
Активен |
3450 |
12.45 |
| C09DB01 |
Amlodipine, Valsartan |
Exforge |
Film‐coated tablet |
10 mg/160 mg |
mg |
28 |
Novartis Europharm Limited, Обединено Кралство |
1 |
tabl. |
- |
43.45 |
0.30466 |
8.53 |
50% |
4.26 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 164/ 20.04.2011; КЦРР-646/19.05.2012 г.; НСР-104/07.06.2013; НСР-2770/17.02.2014; НСР-4933/22.10.2014; НСР-9790/14.07.2016 |
42584 |
08.09.2012 |
|
Активен |
3325 |
13.65 |
| C09DB01 |
Amlodipine, Valsartan |
Valsavil AM |
Film‐coated tablet |
10 mg/160 mg |
mg |
30 |
Stada Arzneimittel AG, Германия |
1 |
tabl. |
|
17.45 |
0.30466 |
9.14 |
50% |
4.57 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-9808/14.07.2016 |
42584 |
|
|
Активен |
15295 |
Без промяна |
| C09DB01 |
Amlodipine, Valsartan |
Valsavil AM |
Film‐coated tablet |
5 mg/160 mg |
mg |
30 |
Stada Arzneimittel AG, Германия |
1 |
tabl. |
|
16.02 |
0.27783 |
8.33 |
50% |
4.17 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-9809/14.07.2016 |
42584 |
|
|
Активен |
15296 |
Без промяна |
| C09DB02 |
Olmesartan medoxomil/ amlodipine (as besilate) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09DB02 |
Olmesartan medoxomil and amlodipine |
Tespadan |
Film‐coated tablet |
20 mg/5 mg |
mg |
28 |
Menarini International Operations Luxembourg S.A., Люксембург |
1 |
tabl. |
- |
41.88 |
0.77516 |
21.7 |
50% |
10.85 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
; НСР-9207/ 05.05.2016 |
02.06.2016 |
|
|
Активен |
3598 |
Без промяна |
| C09DB02 |
Olmesartan medoxomil and amlodipine |
Tespadan |
Film‐coated tablet |
40 mg/5 mg |
mg |
28 |
Menarini International Operations Luxembourg S.A., Люксембург |
1 |
tabl. |
- |
43.31 |
1.52349 |
42.66 |
50% |
21.33 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-1627/01.11.2013; НСР-3983/30.06.2014; КП-288/19.05.2015 и НСР-5675/18.02.2015 |
02.06.2015 |
|
|
Активен |
3946 |
Без промяна |
| C09DB04 |
Telmisartan/ Amlodipine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09DB04 |
Telmisartan, Amlodipine |
Telfort |
Tablet |
80 mg/ 5 |
mg |
28 |
Zentiva k.s., Чешка република |
1 |
tabl |
- |
37.63 |
0.38755 |
10.85 |
50% |
5.42 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-9472/ 09.06.2016 |
02.07.2016 |
|
|
Активен |
15214 |
17.36 |
| C09DB04 |
Telmisartan, Amlodipine |
TWYNSTA |
Tablet |
80mg/ 10 mg |
mg |
28 |
Boehringer Ingelheim International GmbH, Германия |
1 |
tabl |
- |
44.93 |
0.41438 |
11.6 |
50% |
5.8 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 199/ 20.09.2011; КЦРР-2604/14.03.2013 г; НСР-4939/22.10.2014; НСР-6481/18.06.2015.; НСР-8561/24.03.2016. |
02.07.2016 |
08.09.2012 |
|
Активен |
3330 |
18.56 |
| C09DB04 |
Telmisartan, Amlodipine |
TWYNSTA |
Tablet |
80mg/ 5 mg |
mg |
28 |
Boehringer Ingelheim International GmbH, Германия |
1 |
tabl |
- |
45.55 |
0.38755 |
10.85 |
50% |
5.42 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 199/ 20.09.2011; КЦРР-2603/14.03.2013 г.; НСР-1948/06.12.2013; НСР-2123/14.12.2013; НСР-4338/05.08.2014.; НСР-6409/12.06.2015.; НСР-7909/28.01.2016. |
02.07.2016 |
08.09.2012 |
|
Активен |
3098 |
17.36 |
| C09DX01 |
Amlodipine/ Valsartan/ Hydrochlorothiazide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09DX01 |
Amlodipine, Valsartan, Hydrochlorothiazide |
Exforge HCT |
Film‐coated tablet |
5 mg/ 160 mg/ 12,5 mg |
mg |
14 |
Novartis Europharm Limited, Обединено Кралство |
1 |
tabl |
- |
20.92 |
0.36158 |
5.06 |
50% |
2.53 |
|
I10,I11.0,I11.9 |
; НСР-9220/ 05.05.2016 |
02.06.2016 |
08.09.2012 |
|
Активен |
3529 |
8.1 |
| C09DX01 |
Amlodipine, Valsartan, Hydrochlorothiazide |
Exforge HCT |
Film‐coated tablet |
10 mg/ 160 mg/ 12,5 mg |
mg |
14 |
Novartis Europharm Limited, Обединено Кралство |
1 |
tabl |
- |
21.91 |
0.38841 |
5.44 |
50% |
2.72 |
|
I10,I11.0,I11.9 |
НСР-4732/02.10.2014; НСР-6901/06.08.2015. |
02.04.2016 |
|
|
Активен |
3214 |
8.7 |
| C09DX01 |
Amlodipine, Valsartan, Hydrochlorothiazide |
Exforge HCT |
Film‐coated tablet |
10 mg/ 160 mg/ 25 mg |
mg |
14 |
Novartis Europharm Limited, Обединено Кралство |
1 |
tabl |
- |
21.96 |
0.47216 |
6.61 |
50% |
3.3 |
|
I10,I11.0,I11.9 |
№ 151/ 14.03.2011; № 175/ 01.06.2011; НСР-6486/18.06.2015 |
02.04.2016 |
08.09.2012 |
|
Активен |
967 |
10.58 |
| C09XA02 |
Aliskiren |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09XA02 |
Aliskiren |
Rasilez |
Film‐coated tablet |
150 |
mg |
28 |
Novartis Europharm Limited, Обединено Кралство |
150 |
mg |
- |
64.64 |
1.30893 |
36.65 |
50% |
18.33 |
|
I10,I11,I12,I13 |
КЦРР-411/05,04,2012; КЦРР-591/18,05,2012 |
03.06.2012 |
08.09.2012 |
|
Заличен |
267 |
|
| C09XA02 |
Aliskiren |
Rasilez |
Film‐coated tablet |
300 |
mg |
28 |
Novartis Europharm Limited, Обединено Кралство |
150 |
mg |
- |
77.12 |
1.30893 |
73.3 |
50% |
36.65 |
|
I10,I11,I12,I13 |
КЦРР-411/05,04,2012; КЦРР-591/18,05,2012 |
03.06.2012 |
08.09.2012 |
|
Заличен |
268 |
|
| C09XA02 |
Aliskiren |
Rasilez |
Film‐coated tablet |
150 |
mg |
14 |
Novartis Europharm Limited, Обединено Кралство |
150 |
mg |
- |
20.26 |
1.44714 |
20.26 |
50% |
10.13 |
|
I11.0,I11.9,I12.9,I13.0 |
№ 201/ 19.10.2011; НСР-2285/13.01.2014; Протокол 53/10.02.2014; КП-230/11.05.2015 и НСР-3725/06.06.2014; НСР-9975/29.07.2016 |
02.07.2016; 02.09.2016. |
08.09.2012 |
|
Активен |
3900 |
Без промяна |
| C09XA02 |
Aliskiren |
Rasilez |
Film‐coated tablet |
300 |
mg |
14 |
Novartis Europharm Limited, Обединено Кралство |
150 |
mg |
- |
35.5 |
1.26786 |
35.5 |
50% |
17.75 |
|
I11.0,I11.9,I12.9,I13.0 |
№ 201/ 19.10.2011; HCP-9316/16.05.2016. |
02.07.2016 |
08.09.2012 |
|
Заличен |
1032 |
|
| C09XA52 |
Aliskiren/ Hydrochlorothiazide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09XA52 |
Aliskiren, Hidrochlorthiazide |
Rasilez HCT |
Film‐coated tablet |
300 mg/ 12,5 mg |
mg |
14 |
Novartis Europharm Limited, Обединено Кралство |
1 |
tabl |
- |
21.31 |
1.52214 |
21.31 |
50% |
10.66 |
|
I10,I11.0,I11.9,I12.9,I13.0 |
; НСР-9317/16.05.2016 |
02.07.2016 |
08.09.2012 |
|
Заличен |
3941 |
|
| C10AA01 |
Simvastatin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C10AA01 |
Simvastatin |
Actalipid |
Film‐coated tablet |
20 |
mg |
28 |
Actavis Group PTC ehf., Исландия |
30 |
mg |
- |
3.02 |
0.11089 |
2.07 |
25% |
0.52 |
|
E10.2,E10.3,E10.4,E10.5,E10.9,E11.2,E11.3,E11.4,E11.5,E11.9,I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
№24/31.07.2009.; КЦРР-1219/13.08.2012 г.; HCР-472/09.07.2013. |
02.08.2013 |
08.09.2012 |
|
Активен |
1961 |
Без промяна |